Valerio Therapeutics Société anonyme (EPA:ALVIO)

EPA:ALVIO Statistics

Total Valuation

EPA:ALVIO has a market cap or net worth of EUR 112.44 million. The enterprise value is 133.29 million.

Market Cap	112.44M
Enterprise Value	133.29M

Important Dates

The next estimated earnings date is Monday, December 29, 2025.

Earnings Date	Dec 29, 2025
Ex-Dividend Date	n/a

Share Statistics

EPA:ALVIO has 488.85 million shares outstanding.

Current Share Class	488.85M
Shares Outstanding	488.85M
Shares Change (YoY)	n/a
Shares Change (QoQ)	-12.27%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	0.08%
Float	397.67M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	61.44
PB Ratio	-13.30
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-10.11
EV / Sales	72.84
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-13.86

Financial Position

The company has a current ratio of 0.35

Current Ratio	0.35
Quick Ratio	0.35
Debt / Equity	n/a
Debt / EBITDA	3.87
Debt / FCF	-2.37
Interest Coverage	-13.35

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-13.78%
Return on Invested Capital (ROIC)	-21.69%
Return on Capital Employed (ROCE)	667.64%
Revenue Per Employee	73,200
Profits Per Employee	-527,240
Employee Count	38
Asset Turnover	0.07
Inventory Turnover	n/a

Taxes

In the past 12 months, EPA:ALVIO has paid 377,000 in taxes.

Income Tax	377,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +183.95% in the last 52 weeks. The beta is 1.65, so EPA:ALVIO's price volatility has been higher than the market average.

Beta (5Y)	1.65
52-Week Price Change	+183.95%
50-Day Moving Average	0.07
200-Day Moving Average	0.06
Relative Strength Index (RSI)	89.82
Average Volume (20 Days)	2,006,799

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, EPA:ALVIO had revenue of EUR 1.83 million and -13.18 million in losses. Loss per share was -0.09.

Revenue	1.83M
Gross Profit	1.09M
Operating Income	-5.49M
Pretax Income	-12.80M
Net Income	-13.18M
EBITDA	5.52M
EBIT	-5.49M
Loss Per Share	-0.09

Balance Sheet

The company has 2.64 million in cash and 22.83 million in debt, giving a net cash position of -20.19 million or -0.04 per share.

Cash & Cash Equivalents	2.64M
Total Debt	22.83M
Net Cash	-20.19M
Net Cash Per Share	-0.04
Equity (Book Value)	-8.45M
Book Value Per Share	-0.06
Working Capital	-13.91M

Cash Flow

In the last 12 months, operating cash flow was -9.23 million and capital expenditures -386,000, giving a free cash flow of -9.62 million.

Operating Cash Flow	-9.23M
Capital Expenditures	-386,000
Free Cash Flow	-9.62M
FCF Per Share	-0.02

Margins

Gross Margin	59.34%
Operating Margin	-299.89%
Pretax Margin	-699.67%
Profit Margin	n/a
EBITDA Margin	301.64%
EBIT Margin	-299.89%
FCF Margin	n/a

Dividends & Yields

EPA:ALVIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-11.72%
FCF Yield	-8.55%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

EPA:ALVIO has an Altman Z-Score of -4.63 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.63
Piotroski F-Score	3